April 18, 2025

Montelukast Effective for Ulcerative Colitis, Study

Montelukast significantly improved remission maintenance in ulcerative colitis patients during corticosteroid tapering, reducing relapse rates and inflammatory markers.

Conexiant

April 18, 2025

Gout Remission Linked to Lower Urate, Fewer Flares

Remission in gout after urate-lowering therapy was seldom after 1 but high after 5 years, finds a five-year NOR-Gout study tracking 211 patients.

Conexiant

April 18, 2025

Retinal Imaging Captures Alzheimer’s and Dementia Risk

The noninvasive, accessible, and scalable modality can predict risk before disease endpoints can be observed.

Conexiant

April 17, 2025

iPSC-Derived Cells Show Promise for Parkinson's

A phase I/II trial demonstrated that allogeneic iPSC-derived dopaminergic progenitors survived, produced dopamine, and did not form tumors.

Conexiant

April 17, 2025

Cardiometabolic Shifts May Predict Dementia

An accelerated decline in BMI and waist circumference, along with fluctuating HDL levels, may signal early cognitive impairments up to a decade before dementia diagnosis, study finds.

The Pathologist

April 17, 2025

Climate Identified as Key Virus Driver

Researchers found Oropouche virus to be underreported during a large-scale study across Latin America, with climate emerging as the primary driver of transmission risk.

Conexiant

April 17, 2025

Eyebrows Signal Understanding Gaps in Conversation

Eyebrow furrows can silently signal 'I've not received enough information.'

Conexiant

April 16, 2025

Triple Drug Combo May Halt Enterovirus Infections

All three components have previously completed clinical trials for other applications and established safety profiles in humans.

Conexiant

April 16, 2025

E-Cigs + Cigarettes: Worse Disease Odds

"There is a need to reassess the assumption that e-cigarette use provides substantial harm reduction across all cigarette-caused diseases, particularly accounting for dual use," warns a comprehensive meta-analysis.

Conexiant